Botanical species · safety record

Curcuma kwangsiensis

The EFSA Compendium of Botanicals holds 8 constituent measurements for Curcuma kwangsiensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Curcuma kwangsiensis S.G.Lee & C.F. Liang

8Constituent measurements
0Safety records
5Cited sources
152Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 152 licensed products naming Curcuma kwangsiensis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Curcuma kwangsiensis - Tuber
  • Curcuma longa - Tuber
  • Curcuma phaeocaulis - Tuber
  • Curcuma wenyujin - Tuber
  • Rhizome
  • Rhizome (processed)
  • Root tuber(s)
  • Tuber

What the records describe

Constituents measured

  • Camphor3
  • Curzerenone2
  • 1,8-cineole1
  • Labdane diterpenes1
  • Sesquiterpene lactones1

Plant parts

  • Roots and other underground parts6
  • Unspecified2

Preparations

  • Essential oil5
  • Solvent extraction1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-cineoleRoots and other underground partsEssential oilGC-MSResolve DOI
CamphorRoots and other underground partsGC-MSResolve DOI
CamphorRoots and other underground partsEssential oilGC-MSResolve DOI
CurzerenoneRoots and other underground partsEssential oilGC-MSResolve DOI
Labdane diterpenesRoots and other underground partsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
CamphorUnspecifiedEssential oilGC-MSNo resolvable identifier
CurzerenoneUnspecifiedEssential oilGC-MSNo resolvable identifier
Sesquiterpene lactonesRoots and other underground partsStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Komatsu, Katsuko., Sasaki, Yohei., Tanaka, Ken., Kuba, Yoshiaki., Fushimi, Hirotoshi., Cai, Shao-Qing. Morphological, genetic, and chemical polymorphism of Curcuma kwangsiensis . Journal of natural medicines, 2008, vol. 62, no. 4, p. 413-422. DOI
  2. Zeng, Jian Hong., Xu, Gang Biao., Chen, Xu. Application of the chromatographic fingerprint for quality control of essential oil from GuangXi Curcuma kwangsiensis . Medicinal chemistry research, 2009, vol. 18, no. 2, p. 158-165. DOI
  3. Ge, Y.-W., Gao, H.-M., Wang, W.-H., Wang, Z.-M. Studies on chemical constituents in Guiyujin (Report I). Chinese pharmaceutical journal, 2007, vol. 42, no. 11, p. 822-823+824.
  4. Schramm, Anja., Ebrahimi, Samad Nejad., Raith, Melanie., Zaugg, Janine., Rueda, Diana C., Hering, Steffen., Hamburger, Matthias. Phytochemical profiling of Curcurna kwangsiensis rhizome extract, and identification of labdane diterpenoids as positive GABA(A) receptor modulators . Phytochemistry, 2013, vol. 96, p. 318-329. DOI
  5. Zeng, Jian-hong., Mo, Xuan-yong., Dai, Ping., Huang, Feng-xiang., Liao, Ying., Wang, Jian-hong., Chen, Xu. Spectrum-effect relationship between fingerprint of essential oil and of anti-tumor effect from Curcuma kwangsiensis. Zhongguo shiyan fangjixue zazhi, 2012, vol. 18, no. 13, p. 91-94.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue